Arginetix
Latest round
- Series A
Last raised
- Jun 2010
Total raised
- $22M
Investors
- 8
About Arginetix
Arginetix is based in Lutherville, US and is a bio-pharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase.
Who invested in Arginetix
8 investors across 3 rounds
See all investors in Arginetix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arginetix
Who invested in Arginetix?
Arginetix has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arginetix raised?
Arginetix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arginetix last raise money?
Arginetix's most recent round on record is a Series A, in Jun 2010.
What does Arginetix do?
Arginetix is based in Lutherville, US and is a bio-pharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase.
Where is Arginetix headquartered?
Arginetix is headquartered in Lutherville, US.
Which VCs invest in companies like Arginetix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Arginetix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Arginetix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.